CTLA4 and posterior cortical atrophy: Concurrently, ICIs such as anti-PD-1/PD-L1 or anti-CTLA-4 agents reinvigorate T-cell-mediated antitumor responses, which are often suppressed in PCa(Catalano et al., 2022).